Bankruptcy filings, week of 2026-08-28

The week of 2026-08-28, 2 companies reported a bankruptcy or receivership to the SEC on Form 8-K under Item 1.03. Open a company for the filing's own words on the petition, chapter, court and case.

In the filings' own words

BioXcel Therapeutics, Inc., 2026-08-28

On August 27, 2026 (the "Petition Date"), BioXcel Therapeutics, Inc. (the "Company") and its subsidiaries OnkosXcel Therapeutics, LLC and OnkosXcel Employee Holdings, LLC (together with the Company, the "Debtors") each filed voluntary petitions for relief under Chapter 11 of the Bankruptcy Code in the United States Bankruptcy Court for the District of Delaware (such court, the "Court" and such cases, the "Cases").

Open the filing

SANGAMO THERAPEUTICS, INC, 2026-08-28

As previously announced, on June 23, 2026, Sangamo Therapeutics, Inc. (the "Company") filed a voluntary petition for relief under Chapter 11 of Title 11 of the United States Code (the "Bankruptcy Code") in the United States Bankruptcy Court for the District of Delaware (the "Bankruptcy Court"), thereby commencing a Chapter 11 case for the Company (the "Chapter 11 Case").

Open the filing

Where this comes from

Public companies report a bankruptcy, a receivership or a similar proceeding to the SEC on Form 8-K under Item 1.03, usually within four business days. Every filing listed here is one of them, linked to the filing itself. The sentences shown are quoted from the filing exactly; where a filing does not state the court, the case or the chapter in one sentence, nothing is shown in its place.

The state is where the company says its business is, and the industry is the one it registered with the SEC. A filing reports what the company filed; it does not say whether creditors will be paid, and neither does this page.

All recent bankruptcy filingsPrevious weekNext week